Asset Scouting (2)

Challenge A listed North American firm needed support with the identification of early-stage in-licensing or acquisition opportunities in the highly competitive field of regenerative medicine....

Challenge A listed North American company needed hands-on support with the identification, assessment and in-licensing of early-stage oncology assets.

Challenge A well-capitalized European pharma company needed on-the-ground support with a search for late stage therapeutics, devices and diagnostics acquisition opportunities in the US. Alacrita was...

Challenge A rapidly growing European-headquartered specialty medtech company wanted to conduct a search for M&A opportunities in the interventional medicine arena.

Challenge A listed North American company needed support with the identification, assessment and in-licensing of early-stage oncology assets.

Asset scouting for a well-capitalized Swiss pharma company Alacrita been engaged by a well-capitalized Swiss pharma company to scout and identify early stage in-licensing opportunities from the New...